期刊文献+

非洲马瘟疫苗的研究进展 被引量:2

Research Progress in Development of Vaccines against African Horse Sickness
下载PDF
导出
摘要 非洲马瘟(African horse sickness,AHS)由非洲马瘟病毒(African horse sickness virus,AHSV)感染马科动物而引起的一种非接触性传播的虫媒病毒病,为世界动物卫生组织法定报告的动物疫病,目前主要流行于亚撒哈拉非洲等地区。库蠓(Culicoides midges)是非洲马瘟的主要媒介昆虫,其在疫区的生长繁殖直接影响着该病的流行状况。非洲马瘟弱毒苗和灭活苗已经商品化并得到广泛地应用,新型基因工程疫苗,如亚单位疫苗、活病毒载体疫苗等,正在研发当中并有望将来进入疫苗市场,作者着重对ASH疫苗的研究现状进行了评述。 African horse sickness (AHS) is a non-contagious, insect borne disease of equids, caused by African horse sick- ness viruses. This disease is included in the single Office International des Epizooties list of notifiable terrestrial animal disea ses, and at present, is enzootie in such areas as sub-Saharan Africa. AHS is mainly transmitted by Culicoides midges, which grow and reproduce in the endemic areas, being responsible for the epidemiological status of this disease. The live attenuated vaccines and inactivated vaccines against AHS have been commercialized and been widely used. The new generation vaccines based on genetic engineering, such as subunit vaccines and viral vector vaccines, are being developed and will probably enter the vaccine marketplace in the future. In this review, we discussed the current status of vaccines against AHS in detail.
出处 《中国畜牧兽医》 CAS 北大核心 2012年第7期209-213,共5页 China Animal Husbandry & Veterinary Medicine
关键词 非洲马瘟 非洲马瘟病毒 弱毒苗 灭活苗 DIVA策略 African horse sickness African horse sickness virus live attenuated vaccine inactivated vaccine DIVA strat
  • 相关文献

参考文献29

  • 1徐守振,尹燕博,王新.动物疫苗中常用抗原灭活剂的研究进展[J].中国畜牧兽医,2010,37(9):162-167. 被引量:40
  • 2Boone J D, Balasuriya U B, Karaca K, et al. Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep[J]. Vaccine, 2007, 25 (4): 672~678.
  • 3Castillo-Olivares J, Calvo-Pinilla E, Casanova I, et al. A modified vaccinia Ankara virus (MVA) vaccine expressing African horse sickness virus (AHSV) VP2 protects against AHSV challenge in an IFNAR-/- mouse model[J]. PLoS One, 2011, 6 (1): e16503.
  • 4Chiam R, Sharp E, Maan S, et al. Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA)[J]. PLoS One, 2009, 4 (6): e5997.
  • 5Clift S J, Williams M C, Gerdes T, et al. Standardization and validation of an immunoperoxidase assay for the detection of African horse sickness virus in formalin-fixed, paraffin-embedded tissues[J]. Journal of Veterinary Diagnostic Investigation, 2009, 21 (5): 655~667.
  • 6du Plessis M, Cloete M, Aitchison H, et al. Protein aggregation complicates the development of baculovirus-expressed African horsesickness virus serotype 5 VP2 subunit vaccines[J]. Onderstepoort Journal of Veterinary Research, 1998, 65 (4): 321~329.
  • 7Guthrie A J, Quan M, Lourens C W, et al. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus[J]. Vaccine, 2009, 27 (33): 4434~4438.
  • 8House C, House J A, Mebus C A. A review of African horse sickness with emphasis on selected vaccines[J]. Annals of the New York Academy of Sciences, 1992, 653: 228~232.
  • 9Kemp G E, Humburg J M, Alhaji I. Isolation and identification of African horse-sickness virus in Nigeria[J]. Veterinary Record, 1971, 89 (4): 127~128.
  • 10Martinez-Torrecuadrada J L, Diaz-Laviada M, Roy P, et al. Full protection against African horsesickness (AHS) in horses induced by baculovirus-derived AHS virus serotype 4 VP2, VP5 and VP7[J]. Journal of General Virology, 1996, 77 ( Pt 6): 1211~1221.

二级参考文献10

共引文献39

同被引文献34

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部